Sun Yat-sen University: Colonic Neoplasms trials
The registry lists 11 Colonic Neoplasms studies with Sun Yat-sen University as lead sponsor. 7 are open to participants now and 0 have results posted.
Phase 2 3Phase 3 4No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort StudyNot yet recruitingNCT07549906Phase 2
- Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled TrialNot yet recruitingNCT07413146Not applicable
- mFOLFOXIRI Plus PD-1 Inhibitor vs mFOLFOX6 as Neoadjuvant Therapy for Locally Advanced Colon CancerNot yet recruitingNCT06890624Phase 2
- Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon CancerNot yet recruitingNCT06790212Phase 2
- Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon CancerRecruitingNCT06485609Not applicable
- MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon CancerRecruitingNCT06204484Not applicable
- Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon CancersRecruitingNCT05194878Phase 3
- Clinical Significance of Marginal Acute Inflammation for Stage II Colon CancerCompletedNCT06135558
- Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon CancerTerminatedNCT03970694Phase 3
- FOLFOX or CAPOX Perioperative Chemotherapy Versus Postoperative Chemotherapy for Locally Advanced Colon Cancer (OPTICAL)Active, not recruitingNCT02572141Phase 3
- Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After ChemotherapyStatus unknownNCT02280278Phase 3